Blog

Neuralstem President And CEO To Present 2014 Trials Overview At 2014 … – Wall Street Journal

Neuralstem President And CEO To Present 2014 Trials Overview At 2014
Wall Street Journal
Neuralstem’s patented technology enables the production of neural stem cells of the brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human

and more

…read more    

2014-01-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.